Oxygenta Pharmaceutical Ltd - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations, 2015 And In Terms Of Aforesaid SEBI Circular Dated May 20, 2020 And All Other Applicable Regulations And Closure Of Trading Window

Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Friday, 12th August, 2022, inter-alia, to consider and approve: 1. The Un-audited Financial Results for the first quarter ended 30th June, 2022: 2. Other Corporate matters As per the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with the Code of conduct to Regulate, Monitor and Report Trading by insiders of the Company, the Trading window for dealing in the equity shares of the Company was closed from 01st July, 2022, till 48 hours after the declaration of financial results for the First quarter ended 30th June, 2022, for all designated persons, their immediate relatives and all connected persons covered under the said Code. This is for your information and records.